GRIGIONI, FRANCO
 Distribuzione geografica
Continente #
NA - Nord America 3.280
EU - Europa 2.044
AS - Asia 1.240
AF - Africa 133
SA - Sud America 6
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.707
Nazione #
US - Stati Uniti d'America 3.268
GB - Regno Unito 609
CN - Cina 399
SG - Singapore 337
VN - Vietnam 336
SE - Svezia 324
DE - Germania 299
IT - Italia 165
UA - Ucraina 144
IE - Irlanda 113
IN - India 104
RU - Federazione Russa 98
FR - Francia 96
CH - Svizzera 61
TG - Togo 49
EE - Estonia 44
ZA - Sudafrica 40
JO - Giordania 26
FI - Finlandia 25
BE - Belgio 23
CI - Costa d'Avorio 20
BG - Bulgaria 17
IR - Iran 14
SC - Seychelles 13
CA - Canada 11
NG - Nigeria 11
JP - Giappone 9
GR - Grecia 6
BR - Brasile 5
RO - Romania 5
AU - Australia 3
HK - Hong Kong 3
NL - Olanda 3
ES - Italia 2
HR - Croazia 2
LB - Libano 2
NO - Norvegia 2
PT - Portogallo 2
UZ - Uzbekistan 2
AT - Austria 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EU - Europa 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MY - Malesia 1
PE - Perù 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TR - Turchia 1
Totale 6.707
Città #
Southend 542
Fairfield 387
Chandler 328
Singapore 294
Ashburn 260
Woodbridge 212
Dong Ket 185
Wilmington 183
Seattle 177
Houston 168
Princeton 161
Ann Arbor 149
Cambridge 147
Dublin 113
Santa Clara 109
Jacksonville 105
Boardman 101
Berlin 67
Bern 57
Westminster 51
Nanjing 50
Padova 50
Lomé 49
Saint Petersburg 34
Jinan 31
Bremen 27
Amman 26
Helsinki 25
Shenyang 24
Beijing 23
Bologna 23
Brussels 23
Redmond 23
San Diego 22
Abidjan 20
Mülheim 18
Nanchang 18
Dearborn 17
Sofia 17
Tianjin 17
Guangzhou 16
New York 15
Changsha 14
Turin 14
Des Moines 13
Mahé 13
Abeokuta 11
Haikou 11
Milan 11
Florence 10
Hebei 10
Falls Church 9
Paris 9
Shanghai 9
Tokyo 9
Jiaxing 8
Norwalk 8
Redwood City 8
Toronto 8
Zhengzhou 8
Kunming 7
Medford 7
Ningbo 7
Verona 7
Harbin 6
Shijiazhuang 6
Chengdu 5
Frankfurt am Main 5
Hangzhou 5
Los Angeles 5
Taizhou 5
Xi'an 5
London 4
Providence 4
Pune 4
Dalian 3
Falkenstein 3
Fuzhou 3
Hefei 3
Moscow 3
Qingdao 3
Quanzhou 3
San Francisco 3
Springfield 3
Stockholm 3
São Paulo 3
Taiyuan 3
Zanjan 3
Andover 2
Ardabil 2
Changzhou 2
Edinburgh 2
Frankfurt Am Main 2
Hounslow 2
Jiangmen 2
Kashan 2
Kirov 2
Kuban 2
Mountain View 2
New Albany 2
Totale 4.692
Nome #
Accuracy of MRI/MRSI-based transrectal ultrasound biopsy in peripheral and transition zones of the prostate gland in patients with prior negative biopsy 255
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 215
Adenocarcinoma in Crohn's disease: the pathologist's experience in a tertiary referral centre of inflammatory bowel disease. 184
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. 179
11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy. 175
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 158
Application of a fluorescent PCR method for molecular diagnosis of posttransplant lymphoproliferative disorders on routine tissue sections. 155
Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. 146
A histopathologic screening method for rational use of organs from prostate-specific antigen-positive multiorgan donors: the Italian Emilia-Romagna Region experience 140
Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. 138
Studies on immunoproteasome in human liver. Part I: absence in fetuses, presence in normal subjects, and increased levels in chronic active hepatitis and cirrhosis 138
The role of lymphadenectomy for liver tumors. Further considerations on the appropriateness of treatment strategy 136
Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation 133
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 131
Molecular monitoring of organ recipients from cancer-affected donors by detection of circulating tumor cells. 128
Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. 127
Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. 121
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 121
Prediction of Three-Year Outcome of Renal Transplantation from Optimal Donors versus Expanded Criteria Donors. 121
Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer 119
Portal vein arterialization: a new surgical option against acute liver failure? 119
Expression of connective tissue growth factor is a prognostic marker for patients with intrahepatic cholangiocarcinoma 118
Endoscopic finding of granular cell tumour associated with leiomyomas in the oesophagus. 116
Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. 114
Expanding the criteria of organ procurement from donors with prostate cancer: the application of the new Italian guidelines. 114
Sextant localization of prostate cancer:comparison between Magnetic Resonance Spectroscopic Imaging and 11C-Choline PET-CT. 108
A novel spectral ultrasonic differentiation method for marking regions of interest in biological tissue: in vitro results for prostate. 107
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 106
Expression of beta-galactoside alpha 2,6 sialyltransferase and of alpha 2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis 106
Efficacy and appropriateness of histological score in prediction of the 3-year outcome of kidney transplantation 104
Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation. 104
Real-time quantitative assay for routine testing of HCV RNA in formalin-fixed, paraffin-embedded liver samples. 103
Histopathological evaluation of recurrent hepatitis C after liver transplantation: A review 101
OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. 101
The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: A retrospective study. 100
Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis 99
Characterization of small nodules in liver cirrhosis. The assessment of the vascular pattern at imaging techniques. The problem of "hypovascular" HCC 97
Toward the definition of immunosuppressive regimens with antitumor activity. 94
Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings. 93
Real time RT-PCR approach for the evaluation of ERBB2 overexpression in breast cancer archival samples: a comparative study with FISH, SISH, and immunohistochemistry. 92
Two years' experience of acute rejection monitoring of intestinal transplant recipients by real-time PCR assessment of granzyme B and perforin up-regulation: considerations on diagnostic accuracy. 90
Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. 90
Strategies for evaluation of suitable donors: Italian experience. 89
Endothelial cell differentiation in hepatocellular adenomas:implications for histopathological diagnosis. 89
Incidence of neoplastic donors in Organizzazione Centro Sud Trapianti area during the 2003-2005 period. 87
Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation. 87
Italian Transplant Research Network. Quality and safety in the Italian donor evaluation process. 80
Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation. 80
Potential of real-time PCR assessment of granzyme B and perforin up-regulation for rejection monitoring in intestinal transplant recipients 77
Italian Transplant Research Network. The Italian multiorgan donor cancer screening protocol: 2002-2005 experience. 71
Insulin-like growth factor (IGF) stimulation of hepatocellular carcinoma (HCC) migration is mediated by divergent regulation of aspartyl-asparagyl B hydroxylase (AAH) and notch 62
Different in situ expression of insulin-like growth factor type II in hepatocellular carcinoma: An in situ hybridization and immunohistochemical study 46
Expression of Epstein-Barr virus-encoded RNA and biological markers in Italian nasopharingeal carcinomas 41
A multiorgan donor cancer screening protocol: The Italian Emilia-Romagna region experience 41
Role and new perspectives of transforming growth factor-α (TGF-α) in adenocarcinoma of the gastro-oesophageal junction 41
Detection of anti-sense transcripts of the insulin-like growth factor-2 gene in Wilms' tumor 39
Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma 39
Primary paraganglioma strictly confined to the liver and mimicking hepatocellular carcinoma: An immunohistochemical and in situ hybridization study 37
Discrepancies between detection of Bcl-2 by in situ hybridization and immunocytochemistry in human prostate cancer tissues 37
High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas 37
Expression, regulation, and function of αV integrins in hepatocellular carcinoma: An in vivo and in vitro study 36
Diagnostic implications of albumin messenger RNA detection and cytokeratin pattern in benign hepatic lesions and biliary cystadenocarcinoma 36
Expression of insulin‐like growth factor II (IGF–II) in human hepatocellular carcinomas: An immunohistochemical study 34
Overexpression of p53 protein and Ki67 proliferative index in hepatocellular carcinoma: An immunohistochemical study on 109 Italian patients 32
Histogenesis of primary liver carcinomas: Strengths and weaknesses of cytokeratin profile and albumin mRNA detection 32
Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane 28
Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours 26
Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: Its specific receptor c- met does 26
Granzyme B and perforin as predictive markers for acute rejection in human intestinal transplantation 22
Expression of cadherins and α-catenin in primary epithelial tumors of the liver 21
Imbalance between cytoproliferation and apoptosis in hepatitis C virus related chronic liver disease 21
Focal nodular hyperplasia of the liver: Composition of the extracellular matrix and expression of cell-cell and cell-matrix adhesion molecules 20
The metabolic organization of the adult human liver: A comparative study of normal, fibrotic, and cirrhotic liver tissue 19
Low p27 expression is an independent predictor of survival for patients with either hilar or peripheral intrahepatic cholangiocarcinoma 19
Fibrolamellar carcinoma of the liver: Composition of the extracellular matrix and expression of cell-matrix and cell-cell adhesion molecules 17
Space-occupying (malignant) lesions of the liver 16
Factors affecting recurrence in Crohn's disease: Results of a prospective audit 12
Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis 11
Helicobacter pylori infection and gastric function in patients with fundic atrophic gastritis 11
Benign lesions of the liver 8
Totale 6.823
Categoria #
all - tutte 19.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.060 0 0 0 0 0 167 217 231 208 107 57 73
2020/2021833 162 66 26 40 8 38 13 47 89 37 38 269
2021/20221.286 202 29 85 119 93 44 28 67 31 62 355 171
2022/20231.410 187 213 72 169 89 96 39 80 254 28 96 87
2023/2024281 27 70 16 26 21 47 14 21 8 13 9 9
2024/2025855 37 285 140 117 213 63 0 0 0 0 0 0
Totale 6.823